Connecting you to content on EBSCOhost

Works by Nakawah, Mohammad O

Results: 6

1

Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.

Published in:

Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01791-x

By:

Faridar, Alireza;
Gamez, Nazaret;
Li, Daling;
Wang, Yanling;
Boradia, Reena;
Thome, Aaron D.;
Zhao, Weihua;
Beers, David R.;
Thonhoff, Jason R.;
Nakawah, Mohammad O.;
Román, Gustavo C.;
Volpi, John J.;
Toledo, Jon B.;
George, Michael;
Davis, Charles S.;
Pascual, Belen;
Grundman, Michael;
Masdeu, Joseph C.;
Appel, Stanley H.

Publication type:

Article

2

A Phase 1 Clinical Trial of IL‐2 in Patients with Alzheimer's Disease: A Regulatory T Cell Expansion Strategy Targeting Inflammation.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.073878

By:

Faridar, Alireza;
Eid, Abdulmunaim M;
Thome, Aaron D;
Zhao, Weihua;
Beers, David;
Pascual, Belen;
Nakawah, Mohammad O;
Roman, Gustavo C;
Davis, Charles S.;
Grundman, Michael;
Masdeu, Joseph C.;
Appel, Stanley H

Publication type:

Article

3

Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.

Published in:

Brain: A Journal of Neurology, 2025, v. 148, n. 1, p. 119, doi. 10.1093/brain/awae234

By:

Appleton, Johanna;
Finn, Quentin;
Zanotti-Fregonara, Paolo;
Yu, Meixiang;
Faridar, Alireza;
Nakawah, Mohammad O;
Zarate, Carlos;
Carrillo, Maria C;
Dickerson, Bradford C;
Rabinovici, Gil D;
Apostolova, Liana G;
Masdeu, Joseph C;
Pascual, Belen

Publication type:

Article

4

Neuroinflammation is highest in areas of disease progression in semantic dementia.

Published in:

2021

By:

Pascual, Belen;
Funk, Quentin;
Zanotti-Fregonara, Paolo;
Cykowski, Matthew D;
Veronese, Mattia;
Rockers, Elijah;
Bradbury, Kathleen;
Yu, Meixiang;
Nakawah, Mohammad O;
Román, Gustavo C;
Schulz, Paul E;
Arumanayagam, Anithachristy S;
Beers, David;
Faridar, Alireza;
Fujita, Masahiro;
Appel, Stanley H;
Masdeu, Joseph C

Publication type:

journal article

5

Neuroinflammation and flortaucipir PET in non‐fluent/agrammatic variant of primary progressive aphasia and/or apraxia of speech.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056501

By:

Pascual, Belen;
Funk, Quentin;
Bradbury, Kathleen;
Jennings, Cassandra;
Rockers, Elijah;
Nakawah, Mohammad O;
Yu, Meixiang;
Beers, David;
Faridar, Alireza;
Appel, Stanley;
Fujita, Masahiro;
Masdeu, Joseph C

Publication type:

Article

6

A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.

Published in:

Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00387-5

By:

Faridar, Alireza;
Eid, Abdulmunaim M.;
Thome, Aaron D.;
Zhao, Weihua;
Beers, David R.;
Pascual, Maria B.;
Nakawah, Mohammad O.;
Roman, Gustavo C.;
Davis, Charles S.;
Grundman, Michael;
Masdeu, Joseph C.;
Appel, Stanley H.

Publication type:

Article